Pharmaceutical Executive-05-01-2015

Pharmaceutical Executive

Pharm Exec's 2015 Brand of the Year: Sovaldi and Harvoni for Hepatitis C

May 12, 2015

Features

35

5

Pharm Exec’s 9th annual Brand of the Year selection is Gilead Science’s back-to-back cures for HCV. We profile how both drugs reversed expectations around the listless product launch and revived industry reputation for startling breakthrough innovations.

From Care to Cure

May 07, 2015

From the Editor

35

5

Pharm Exec's 2015 Brand of the Year Sovaldi and Harvoni are huge game-changers for Hepatitis C, but the big-picture impact will come down to how well the market aligns pricing, distribution, and access toward the broader goal of making sure that those patients who need the cure, get the cure.

Fake Medications, Real Solutions

May 01, 2015

Columns

35

5

Tactics pharma leaders can implement to stem the continued global threat of counterfeit drugs.

Welcome to the HTA Jungle

May 01, 2015

Columns

35

5

Edging through the complex terrain that is health technology assessment in Europe

Country Report: Korea

May 01, 2015

Special Sponsored Section

35

5

Once focused mainly on generic medicines, Korea’s pharma sector has leveraged significant new investments in R&D to transform itself into a true player in the global market-with aspirations as a future top-tier contributor to new medicines innovation.